Inhibition of p38 MAPK and AMPK restores adenosine-induced cardioprotection in hearts stressed by antecedent ischemia by altering glucose utilization

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 293, Issue 2, 2007, Pages

  Jaswal, Jagdip S ^a   Gandhi, Manoj ^a   Finegan, Barry A ^a   Dyck, Jason R B ^a   Clanachan, Alexander S ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

5 adenosine monophosphate activated protein kinase; Glucose metabolism; p38 mitogen activated protein kinase

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 HYDROXYPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ADENOSINE; ADENYLATE KINASE; GLUCOSE; GLYCOGEN; INSULIN; MITOGEN ACTIVATED PROTEIN KINASE P38; MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR; PALMITIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; GLUCOSE METABOLISM; GLUCOSE OXIDATION; GLUCOSE UTILIZATION; GLYCOGEN SYNTHESIS; GLYCOLYSIS; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HEART STRESS; METABOLIC STRESS; NONHUMAN; PRIORITY JOURNAL; RAT;

ADENOSINE; ANIMALS; CARDIOTONIC AGENTS; DISEASE MODELS, ANIMAL; GLUCOSE; GLYCOGEN; GLYCOLYSIS; HYDROGEN-ION CONCENTRATION; IMIDAZOLES; MALE; MULTIENZYME COMPLEXES; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; PROTEIN-SERINE-THREONINE KINASES; PYRIDINES; RATS; RATS, SPRAGUE-DAWLEY; SEVERITY OF ILLNESS INDEX; VENTRICULAR FUNCTION, LEFT;

EID: 34547872783     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00455.2007     Document Type: Article

References (38)

1. Barnes BR, Glund S, Long YC, Hjalm G, Andersson L, Zierath JR. 5′-AMP-activated protein kinase regulates skeletal muscle glycogen content and ergogenics. FASEB J 19: 773-779, 2005.
2. Clanachan AS, Jaswal JS, Gandhi M, Bottorff DA, Coughlin J, Finegan BA, Stone JC. Effects of inhibition of myocardial extracellular-responsive kinase and p38 mitogen-activated protein kinase on mechanical function of rat hearts after prolonged hypothermic storage. Transplantation 75: 173-180, 2003.
3. Davies SP, Carling D, Hardie DG. Tissue distribution of the AMP-activated protein kinase, and lack of activation by cyclic-AMP-dependent protein kinase, studied using a specific and sensitive peptide assay. Eur J Biochem 186: 123-128, 1989.
4. Depre C, Rider MH, Vietch K, Hue L. Role of fructose 2,6-biphosphate in the control of heart glycolysis. J Biol Chem 268: 13274-13279, 1993.
5. Finegan BA, Clanachan AS, Coulson CS, Lopaschuk GD. Adenosine modification of energy substrate use in hearts perfused with fatty acids. Am J Physiol Heart Circ Physiol 262: H1501-H1507, 1992.
6. Finegan BA, Gandhi M, Lopaschuk GD, Clanachan AS. Antecedent ischemia reverses effects of adenosine on glycolysis and mechanical function of working rat hearts. Am J Physiol Heart Circ Physiol 271: H2116-H2125, 1996.
7. Finegan BA, Lopaschuk GD, Coulson CS, Clanachan AS. Adenosine alters glucose use during ischemia and reperfusion in isolated rat hearts. Circulation 87: 900-908, 1993.
8. Finegan BA, Lopaschuk GD, Gandhi M, Clanachan AS. Inhibtion of glycolysis and enhanced mechanical function of working rat hearts as a result of adenosine A1 receptor stimulation during reperfusion following ischemia. Br J Pharmacol 118: 355-363, 1996.
9. Fralix TA, Murphy E, London RE, Steenbergen C. Protective effects of adenosine in the perfused rat heart: changes in metabolism and intracellular ion homeostasis. Am J Physiol Cell Physiol 264: C986-C994, 1993.
10. Goodwin GW, Ahmad F, Taegtmeyer H. Preferential oxidation of glycogen in isolated working rat heart. J Clin Invest 97: 1409-1416, 1996.
11. Gysembergh A, Simkhovich BZ, Kloner RA, Przyklenk K. p38 MAPK activity is not increased early during coronary artery occlusion in preconditioned versus control rabbit heart. J Mol Cell Cardiol 33: 681-690, 2001.
12. Henning SL, Wambolt RB, Schonekess BO, Lopaschuk GD, Allard MF. Contribution of glycogen to aerobic myocardial glucose utilization. Circulation 93: 1549-1555, 1996.
13. Jaswal JS, Gandhi M, Finegan BA, Dyck JRB, Clanachan AS. Effects of adenosine on myocardial glucose and palmitate metabolism after transient ischemia: role of 5′-AMP activated protein kinase. Am J Physiol Heart Circ Physiol 291: H1883-H1892, 2006.
14. Jaswal JS, Gandhi M, Finegan BA, Dyck JRB, Clanachan AS. p38 mitogen-activated protein kinase mediates adenosine-induced alterations in myocardial glucose utilization via 5′-AMP activated protein kinase. Am J Physiol Heart Circ Physiol 292: H1978-H1985, 2007.
15. Jorgensen SB, Nielsen JN, Birk JB, Olsen GS, Viollet B, Andreelli F, Schjerling P, Vaulont S, Hardie DG, Hansen BF, Richter EA, Wojtaszewski JF. The α2-5′AMP-activated protein kinase is a site 2 glycogen synthase kinase in skeletal muscle and is responsive to glucose loading. Diabetes 53: 3074-3081, 2004.
16. Kaiser RA, Lyons JM, Duffy JY, Wagner CJ, MacLean KM, O'Neill TP, Pearl JM, Molkentin JD. Inhibition of p38 MAPK reduces myocardial infarction injury in the mouse but not pig after ischemia-reperfusion. Am J Physiol Heart Circ Physiol 289: H2747-H2751, 2005.
17. Kudo N, Barr AJ, Barr RL, Desai S, Lopaschuk GD. High rates of fatty acid oxidation during reperfusion of ischemic hearts are associated with a decrease in malonyl-CoA levels due to an increase in 5′-AMP activated protein kinase inhibition of acetyl-CoA carboxylase. J Biol Chem 270: 17513-17520, 1995.
18. Kudo N, Gillespie JG, Kung L, Witters LA, Schulz R, Clanachan AS, Lopaschuk GD. Characterization of 5′AMP-activated protein kinase activity in the heart and its role in inhibiting acetyl-CoA carboxylase during reperfusion following ischemia. Biochim Biophys Acta 1301: 67-75, 1996.
19. Li J, Miller EJ, Ninomiya-Tsuji J, Russell, 3rd RR, Young LH. AMP-activated protein kinase activates p38 mitogen-activated protein kinase by increasing recruitment of p38 MAPK to TAB1 in the ischemic heart. Circ Res 97: 872-879, 2005.
20. Liu B, Clanachan AS, Schulz R, Lopaschuk GD. Cardiac efficiency is improved after ischemia by altering both the source and fate of protons. Circ Res 79: 940-948, 1996.
21. Liu Q, Docherty JC, Rendell JC, Clanachan AS, Lopaschuk GD. High levels of fatty acids delay the recovery of intracellular pH and cardiac efficiency in post-ischemic hearts by inhibiting glucose oxidation. J Am Coll Cardiol 39: 718-725, 2002.
22. Ma XL, Kumar S, Gao F, Louden CS, Lopez BL, Christopher TA, Wang C, Lee JC, Feuerstein GZ, Yue TL. Inhibition of p38 mitogen-activated protein kinase decreases cardiomyocyte apoptosis and improves cardiac function after myocardial ischemia and reperfusion. Circulation 99: 1685-1691, 1999.
23. Marsin AS, Bertrand L, Rider MH, Deprez J, Beauloye C, Vincent MF, Van den Berghe G, Carling D, Hue L. Phosphorylation and activation of heart PFK-2 has a role in the stimulation of glycolysis during ischaemia. Curr Biol 10: 1247-1255, 2000.
24. Martindale JJ, Wall JA, Martinez-Longoria DM, Aryal P, Rockman HA, Guom Y, Bolli R, Glembotski CC. Overexpression of mitogen activated protein kinase kinase 6 in the heart improves functional recovery from ischemia in vitro and protects against myocardial infarction in vivo. J Biol Chem 280: 669-676, 2004.
25. Maulik N, Watanabe M, Zu YL, Huang CK, Cordis GA, Schley JA, Das DK. Ischemic preconditioning triggers the activation of MAP kinases and MAPKAP kinase 2 in rat hearts. FEBS Lett 396: 233-237, 1996.
26. Mubagwa K, Flameng W. Adenosine, adenosine receptors and myocardial protection: an updated overview. Cardiovasc Res 52: 25-39, 2001.
27. Ping P, Zhang J, Huang S, Cao X, Tang XL, Li RC, Zhang YT, Qui Y, Clerk A, Sugden P, Han J, Bolli R. PKC-dependent activation of p46/p54 JNKs during ischemic preconditioning in conscious rabbits. Am J Physiol Heart Circ Physiol 277: H1771-H1785, 1999.
28. Rusell, 3rd RR, Li J, Coven DL, Pypaert M, Zechner C, Palmeri M, Giordano FJ, Mu J, Birnbaum MJ, Young LH. AMP-activated protein kinase mediates ischemic glucose uptake and prevents postischemic cardiac dysfunction, apoptosis, and injury. J Clin Invest 114: 495-503, 2004.
29. Sambandam N, Lopaschuk GD. AMP-activated protein kinase (AMPK) control of fatty acid and glucose metabolism in the ischemic heart. Prog Lipid Res 42: 238-256, 2003.
30. Shibata R, Sato K, Pimentel DR, Takemura Y, Kihara S, Ohashi K, Funahashi T, Ouchi N, Walsh K. Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK- and COX-2-dependent mechanisms. Nat Med 11: 1096-1103, 2005.
31. Soltys CL, Buchholz L, Gandhi M, Clanachan AS, Walsh K, Dyck JR. Phosphorylation of cardiac protein kinase B is regulated by palmitate. Am J Physiol Heart Circ Physiol 283: H1056-H1064, 2002.
32. Sommerschild HT, Kirkeboen KA. Adenosine and cardioprotection during ischaemia and reperfusion-an overview. Acta Anaesthesiol Scand 44: 1038-1055, 2000.
33. + channels. J Cell Physiol 210: 224-236, 2007.
34. The Multicenter Study of Perioperative Ischemia (McSPI) Research Group. Effects of acadesine on the incidence of myocardial infarction and adverse outcomes after coronary artery bypass graft surgery. Anesthesiology 83: 658-673, 1995.
35. Wang M, Tsai BM, Turrrentine MW, Mahomed Y, Brown JW, Meldrum DR. p38 mitogen activated protein kinase mediates both death signaling and functional depression in the heart. Ann Thorac Surg 80: 2235-2241, 2005.
36. Weinbrenner C, Liu GS, Cohen MV, Downey JM. Phosphorylation of tyrosine 182 of p38 mitogen-activated protein kinase correlates with the protection of preconditioning in the rabbit heart. J Mol Cell Cardiol 29: 2283-2291, 1997.
37. Xi X, Han J, Zhang JZ. Stimulation of glucose transport by AMP-activated protein kinase via p38 mitogen activated protein kinase. J Biol Chem 276: 41029-41034, 2001.
38. Yada M, Shinamoto A, Hampton CR, Chong AJ, Takayama H, Rothnie CL, Spring DJ, Shimpo H, Yada I, Pohlman TH, Verrier ED. FR167653 diminishes infarct size in a murine model of myocardial ischemia-reperfusion injury. J Thorac Cardiovasc Surg 128: 588-594, 2004.